Capillary enzyme immunosorbent assay (CapELISA) is a modification of the standard enzyme immunosorbent assay which permits rapid detection of viral antigens in clinical specimens. The capillary tube format provides a very large reactive surface relative to the sample size. The close proximity of antigen to antibody in the tube optimizes the reaction, resulting in increased sensitivity and shorter incubation requirements.
The enzyme immunosorbent assay (EIA) is a widely used and accepted method for detecting antibodies to many viral antigens. In its usual format, however, it is less effective as a method for detecting viral antigens in clinical specimens, especially when a relatively small amount of antigen is present. Recent methods to amplify sensitivity of the EIA have included increasing the amount of reactive surface and of contact between reactants of interest, e.g., beads (7), nitrocellulose disks (5), capillaries (2) ; improving the bonding and strength of the detector reagent, e.g., biotin-avidin (3, 4) ; and increasing the speed and sensitivity of the substrate, e.g., fluorescent and chemiluminescent substrates (9) . A method which incorporates a number of these modifications of the standard EIA and which permits rapid detection of viral antigens in clinical specimens has been developed at Microbiological Associates, Inc. It employs a plastic capillary as the solid phase, a biotin-avidin detection system, and a fluorescent substrate and is called CapELISA.
The plastic capillary provides a very large reactive surface relative to sample size, and the forced close proximity of antigen to antibody optimizes the reaction between the two entities. Thus, increased sensitivity and shorter incubation times can be achieved. Recent use of the high avidity of avidin for biotin and the capacity of avidin to bind four molecules of biotin has made it possible to amplify the detector signal of the EIA (4, 6). Fluorescent substrates have been shown to be 100 to 1,000 times more sensitive than colorigenic substrates (9 (Fig. 1) .
The pretreated capillary is sensitized by adding 100 pul of capture antibody, in this case rabbit anti-HSV antibody (Dako B114), diluted 1:100 in coating buffer (pH 9.6) (C buffer: sodium carbonate, 1 Assay procedure. (i) Draw 100 pul of tissue culture-grown HSV (1:1,000), as positive control, clinical sample, or sample collection medium, as negative control, diluted in sample diluent (TBS with 1% normal rabbit serum, 1% normal swine serum, and 0.2% bovine serum albumin) into the sensitized tube and incubate at RT for 30 min. Wash the capillary as above.
(ii) Draw 100 pul of biotin-labeled rabbit anti-HSV diluted 1:100 in sample diluent into the tube and incubate at RT for 15 min. Wash as above.
(iii) Draw 100 pul of avidin-alkaline phosphatase diluted 1:400 in sample diluent into the tube and incubate at RT for 15 min. Wash as above.
(iv) Draw 100 pil of 0.025 M 4-methylumbelliferyl phosphate in AMP working buffer (Sigma 960-7) with 0.01% MgCI2 into the tube.
(v) Read with a hand-held, long-wave black light, (e.g., UV Products, San Gabriel, Calif.) after s15 min. Controls for minimal nonspecific background allow easy distinction between fluorescent and nonfluorescent samples.
Parameters of the HSV antigen assay were first determined with a culture-grown virus stain (HSV type 1, MacIntyre VR3) and control antigen. The clinical samples tested were part of a study of herpesvirus in pregnant women and attendees at a maternity center and were supplied by Lata Nerurkar, National Institutes of Health. These samples were collected by rubbing lesions in the genital or vaginal area with cotton swabs. The swabs were placed in 3 ml of Eagle minimum essential medium containing streptomycin, penicillin, and nystatin (collection medium) and frozen at -70°C. Standard tissue culture technique in tube cultures was used by L. Nerurkar to determine which samples were positive. A 200-pul portion from the clinical sample was added to human foreskin fibroblast monolayers (Flow 7000). After absorption overnight, fresh Eagle minimal essential medium with 2% fetal calf serum was added. The cultures were incubated in a 5% C02 incubator for 7 to 10 days. They were checked daily for typical cytopathic effect for 5 days and every other day thereafter. For the CapELISA, specimens were tested directly from the collection medium or diluted 1:2 in TBS. Controls consisted of tissue culturegrown virus (1:1,000) and sample collection medium diluted in TBS.
RESULTS
With tissue culture-grown antigen, CapELISA could detect Because the test reagents are very sensitive, great care must be taken to ensure minimal background reading. Careful washing and wiping of the tips after each step will greatly reduce background.
The fluorescent substrate is extremely sensitive, and any contamination in the substrate buffer will be reflected in the test. The substrate should be prepared fresh each day and should be protected from light. For use, it is measured into clean microtiter wells so that no cross contamination occurs by dipping the capillary into the reagent.
DISCUSSION
The modifications of EIA incorporated in CapELISA resulted in a simple, sensitive, and rapid assay suitable for use in detecting herpesviral antigen in clinical specimens in under 2 h. The plastic capillary can be treated to bind proteins consistently and is sturdy enough to be fieldworthy. It provides a large reactive surface relative to sample volume, and the forced close proximity of antigen to antibody optimizes the reaction between them. It also reduces the dependence on temperature and time. The detector system is more sensitive owing to the avidity of the avidin-biotin bond and to the potential for amplification through use of an avidin-biotin complex. The sensitivity is further increased by use of a fluorescent rather than a colorigenic substrate. The fluorescence develops rapidly and is readily visible when viewed with an inexpensive hand-held long-wave black light.
The use of biotin-avidin amplification in EIAs for rapid detection of HSV antigen in clinical samples has been shown to be useful (1, 6) . These assays performed in microtiter plates require about 4 h, and Nerurkar et al. (6) using streptavidin reported a sensitivity of 95.6% and a specificity of 91.4% compared with standard tissue culture methods. The plate assay is well suited to large-scale assays in which many samples are to be tested. In this study we developed a method to simplify the methodology and increase sensitivity by using the capillary tube format for the test reaction. Thus, CapELISA is better suited to small sample numbers and situations in which results within 2 h are advantageous. Also, if negative samples are rerun by multiexposure of sample to the solid phase, the sensitivity of the assay can be increased even more. The test requires neither sophisticated training nor instrumentation and should be relatively inexpensive.
